Cognition, fatigue, depression and health-related quality of life in early multiple sclerosis: baseline data from CogniMS, a multinational longitudinal study
Phase of Trial: Phase IV
Latest Information Update: 28 Aug 2014
At a glance
- Drugs Interferon beta-1b (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- Acronyms CogniMS
- Sponsors Bayer HealthCare Pharmaceuticals
- 02 Oct 2008 New trial record.
- 18 Sep 2008 Results were presented at the World Congress on Treatment and Research in Multiple Sclerosis.